Active Cancer Biomarkers Grants

PI Name Organization - Companysort descending Title Major Program / Research Group FOA
Iagaru, Andrei Stanford University Molecular Imaging Methods for the Detection of Pancreatic Ductal Adenocarcinoma Pancreatic Cancer Detection Consortium PAR-15-289: The Pancreatic Cancer Detection Consortium
Pitteri, Sharon Stanford University Glycosylation and Immune Evasion in Urologic Tumors Alliance of Glycobiologists for Cancer Research PAR-17-206: Alliance of Glycobiologists for Cancer Research: Translational Tumor Glycomics Laboratories
Bertozzi, Carolyn Stanford University Chemical Glycoproteomics PA-20-185: NIH Research Project Grant
Wu, Yun State University Of New York At Buffalo Exosome-Protein-microRNA-OneStop (Exo-PROS) biosensor: a new liquid biopsy for cancer screening and early detection Innovative Technology Development for Cancer Research RFA-CA-18-002: Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research
Thakur, Mathew Laxman Thomas Jefferson University Noninvasive, Uniplex, Molecular, Pathomic Urinary Assay for Detection of Prostate Cancer Consortium for Imaging and Biomarkers PAR-19-264: Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer
Halpern, Ethan J Thomas Jefferson University Prostate Cancer Diagnosis by Multiparametric Ultrasound PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Sutcliffe, Julie L University Of California At Davis Peptide-based targeted molecular imaging for early detection in pancreatic cancer Pancreatic Cancer Detection Consortium PAR-15-289: The Pancreatic Cancer Detection Consortium
Li, Wenyuan University Of California Los Angeles Informatics resources for liquid biopsy research PAR-15-332: Early-Stage Development of Informatics Technologies for Cancer Research and Management
Wong, David T University Of California Los Angeles Advancing EFIRM-Liquid Biopsy (eLB) to a CLIA-Certified Laboratory Developed Test (eLB-LDT) for Detection of Actionable EGFR Mutations in NSCLC Patients PAR-15-095: Assay Validation For High Quality Markers For NCI-Supported Clinical Trials (UH2/UH3)
Wong, David T University Of California Los Angeles EFIRM-Liquid Biopsy (eLB): Ultrasensitive ctDNA and miRNA Detection for Early Assessment of Lung Cancer Liquid Biopsy Consortium RFA-CA-17-029: Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment
Zhou, Xianghong Jasmine University Of California Los Angeles The UCLA Center in Early Detection of Liver Cancer Translational Liver Consortium RFA-CA-17-025: Consortium on Translational Research in Early Detection of Liver Cancer (Clinical and Research Centers (U01)
Zhu, Yazhen University Of California Los Angeles Biomimetic NanoVilli Chips for Extracellular Vesicles in Hepatocellular Carcinoma PAR-16-277: Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection
Zhu, Yazhen University Of California Los Angeles Extracellular Vesicle-Based Digital Scoring Assay for Detecting Early-stage Hepatocellular Carcinoma PAR-20-053: Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection
Dubinett, Steven M. University Of California Los Angeles Integrated Molecular, Cellular, and Imaging Characterization of Screen-Detected Lung Cancer Molecular and Cellular Characterization RFA-CA-14-010: Molecular and Cellular Characterization of Screen-Detected Lesions
Sharma, Shivani University Of California Los Angeles Nanoscale Structure and Bio-Molecular Heterogeneity of "Purified" Exosomes PAR-16-277: Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection

Pages